|Articles|June 16, 2019
What’s new from Bausch + Lomb for U.S. anterior segment surgeons
Author(s)Julianne Mobilian
Bausch + Lomb provides a company update at the 2019 ASCRS meeting.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Optigo: Lead anti-VEGF program advancing toward IND-enabling studies
2
AAO 2025: Advancements in laser refractive surgery
3
Q&A: Anat Loewenstein discusses the use of home OCT
4
Opus Genetics has Type B RMAT meeting with FDA for its gene therapy candidate, OPGx-LCA5
5














































.png)


